Involvement of the endothelin ETB receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 4, 2007, Pages 280-285

  Kawanishi, Hideaki ^a   Hasegawa, Youichi ^a   Nakano, Daisuke ^a   Ohkita, Mamoru ^a   Takaoka, Masanori ^a   Ohno, Yukihiro ^b   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Deoxycorticosterone acetate (DOCA) salt hypertension; Endothelin 1; ET A receptor; ETB receptor; Gender difference; Superoxide

Indexed keywords

ATRASENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; SUPEROXIDE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE DELETION; HYPERTENSION; MALE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; RAT; RECEPTOR GENE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DOPAMINE BETA-HYDROXYLASE; ENDOTHELIN-1; FEMALE; HYPERTENSION; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN SIZE; OVARIECTOMY; PYRROLIDINES; RATS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SEX FACTORS; SUPEROXIDES; UTERUS; WEIGHT GAIN;

EID: 33846960184     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04580.x     Document Type: Article

References (42)

1. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
2. Goto K, Hama H, Kasuya Y. Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacol. 1996; 72: 261-90.
3. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-2.
4. Sakurai T, Yanagisawa M, Takuwa T et al. Cloning of a cDNA encoding a nonisopeptide-selective subtype of an endothelin receptor. Nature 1990; 348: 732-5.
5. Schiffrin EL. Role of endothelin-1 in hypertension. Hypertension 1999; 34: 876-81.
6. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br. J. Pharmacol. 1995; 114: 925-30.
7. Kassab S, Miller T, Novak J et al. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 1998; 31: 397-402.
8. Day R, Lariviere R, Schiffrin EL. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am. J. Hypertens. 1995; 8: 294-300.
9. A-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats. Jpn. J. Pharmacol. 1996; 70: 313-19.
10. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension 1994; 24: 183-8.
11. A receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Am. J. Physiol. 1998; 275: R245-52.
12. Matsumura Y, Hashimoto N, Taira S et al. Different contribution of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension 1999; 33: 759-65.
13. Matsumura Y, Kuro T, Kobayashi Y et al. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension. Circulation 2000; 102: 2765-73.
14. Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 1997; 29: 494-9.
15. B receptor-mediated vascular responses. Br. J. Pharmacol. 2000; 130: 1092-8.
16. David FL, Carvalho MHC, Cobra ALN et al. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 2001; 38: 692-6.
17. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 2004; 44: 390-1.
18. Gariepy CE, Williams SC, Richardson JA et al. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J. Clin. Invest. 1998; 102: 1092-101.
19. Gariepy CE, Ohuchi T, Williams SC et al. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J. Clin. Invest. 2000; 105: 925-33.
20. A-selective receptor antagonist. J. Pharmacol. Exp. Ther. 1996; 276: 473-81.
21. Skatchkov MP, Sperling D, Hink U et al. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem. Biophys. Res. Commun. 1999; 254: 319-24.
22. Matsumura Y, Ikegawa R, Takaoka M, Morimoto S. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem. Biophys. Res. Commun. 1990; 167: 203-10.
23. Hexum TD, Hoeger C, River JE, Baird A, Brown MR. Characterization of endothelin secretion by vascular endothelial cells. Biochem. Biophys. Res. Commun. 1990; 167: 294-300.
24. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 1991; 325: 756-62.
25. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996; 10: 615-24.
26. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999; 340: 1801-11.
27. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308: 1583-7.
28. Dantas APV, Franco MCP, Silva-Antonialli MM et al. Gender differences in superoxide generation in microvessels of hypertensive rats; role of NAD(P)H-oxidase. Cardiovasc. Res. 2004; 61: 22-9.
29. Dantas APV, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MHC. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39: 405-11.
30. Lassegue B, Griendling KK. Reactive oxygen species in hypertension: An update. Am. J. Hypertens. 2004; 17: 852-60.
31. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 2001; 9: 741-8.
32. Rajagopalan S, Kurz S, Münzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996; 97: 1916-23.
33. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: Role of the endothelium. Hypertension 1999; 33: 1353-8.
34. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl Acad. Sci. USA 1991; 88: 10 045-8.
35. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95: 588-93.
36. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001; 38: 1107-11.
37. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001; 37: 781-6.
38. Elmarakby AA, Loomis ED, Pollock JS, Pollock DM. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 2005; 45: 283-7.
39. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000; 101: 1722-8.
40. A-NADPH oxidase pathway in low-renin hypertension. Circulation 2003; 107: 1053-8.
41. B receptor-deficient rats: Effect of a high salt diet. Hypertension 2003; 41: 657-62.
42. Sullivan JC, Pollock JS, Pollock DM. Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats. Exp. Biol. Med. 2006; 231: 818-23.